MTOR and gastric carcinoma: Most of the genetic mutations in gastric carcinoma correlate with changes in biological signals, such as those in the phosphatidylinositol 3-kinase/AKT/mammalian target of the rapamycin pathway (PI3K/AKT/mTOR pathway) [4].